NFE2L2 and neoplasm: We demonstrate that modulation of Nrf2 can sensitise CRC cells to the cytotoxic effects of irinotecan in vitro, and that brusatol can inhibit tumour growth in a syngeneic orthotopic mouse model of CRC.